Dr. Maureen Gannon featured on News Channel 4 segment "4 Your Community"
Genetic screen in worms reveals critical step in insulin synthesis
Patrick Hu, MD, PhD, identified a previously unknown step in insulin synthesis, providing new clues to diabetes pathogenesis.
Diabetes drug study explores cardiovascular risks for patients with kidney disease
Over the years there has been uncertainty over which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease. An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on this issue.
Discovery may point to better treatments for Type 1 diabetes
Researchers at Vanderbilt University Medical Center led by an assistant professor of Pediatrics have made a paradigm-shifting discovery that could lead to new treatments, better health and longer life for patients with Type 1 diabetes.
Study Drug Delays Type 1 Diabetes in High Risk Children and Adults
A drug that targets the immune system can delay the onset of type 1 diabetes an average of two years in children and adults at high risk, according to findings from TrialNet’s Teplizumab (anti-CD3) Prevention Study published in the New England Journal of Medicine. Dr. Bill Russell is the PI of the TrialNet project.
Academic Pediatric Association honors Barkin
Shari Barkin, MD, MSHS, division chief of General Pediatrics at Monroe Carell Jr. Children’s Hospital at Vanderbilt, was honored recently with the 2019 Academic Pediatric Association (APA) Research Award.
Diabetes study reveals decline in pancreas volume for some
Researchers with the Vanderbilt Diabetes Research and Training Center (DRTC) have discovered a progressive decline in pancreas volume over a one-year period in children and adolescents with newly diagnosed Type 1 diabetes.
Vanderbilt scientists report new modeling of brain signaling
Heidi Hamm, Ph.D. and colleagues have generated a new mouse model with defects in SNAP25, a SNARE protein,which decreased the inhibition of neurotransmitter exocytosis and led to physiological and behavioral phenotypes.
Sheila Collins, Ph.D. has been featured as one of Diabetes Forecast magazine's "5 Women Make Waves in Diabetes Research."
Dr. Collins' research on brown fat cells and white fat cells may lead to the development of treatments to combat type 2 diabetes and associated cardiovascular disease.